A Phase 2B clinical trial was just completed that found psilocybin, the “active ingredient” in hallucinogenic/psychedelic mushrooms—or “magic mushrooms—is remarkably effective in treating severe cases of depression. We’ll get into a bit of the background, how we got here, and what we can expect moving forward. We’ll also talk a little bit about the companies that are making progress towards bringing this once-taboo class of substances to a doctor’s office near you.
1. COMPASS Pathways Announcements of Phase 2B clinical trial results: https://ir.compasspathways.com/news-releases/news-release-details/compass-pathways-announces-positive-topline-results
2. (My video) Psilocybin vs. SSRIs: https://www.youtube.com/watch?v=mp_U-tErZSo&t=0s
3. (My video) Can psilocybin treat depression?: https://www.youtube.com/watch?v=-8g0qdXZNWQ
I’m a PhD in neuroscience at the University of Pennsylvania, and I think of this kind of like office hours with a teacher where you can discuss anything you find interesting.
I have a podcast, Wired to be Weird, about the brain with episodes devoted to specific topics – like why we dream & fall in love to why people develop dementia or déjà vu. You can get it wherever podcasts are found.
Here’s one place: http://anthropoid.science/podcast
Do you dig the idea of a weekly live conversation about science? I certainly do! I know not everyone is in a position to support people in this way — but, if you are, here’s my Patreon: https://patreon.com/anthropoid